Table 2

Association between baseline cardiometabolic comorbidities, cardiovascular/renal complications and all-cause death

Primary outcomesSecondary outcomes
Any complicationAll-cause deathHeart failureArrhythmiaCardiac ischaemiaCardiac arrestCoagulation complicationsStrokeRenal injury
OR (95% CI)OR (95% CI)OR (95% CI)OR (95% CI)OR (95% CI)OR (95% CI)Or (95% CI)Or (95% CI)
Any cardiometabolic comorbidity (ref: No)*1.93 (1.84 to 2.02)1.21 (1.16 to 1.27)4.19 (3.56 to 4.94)1.69 (1.56 to 1.83)2.61 (2.11 to 3.23)1.24 (1.09 to 1.42)1.49 (1.34 to 1.66)1.19 (1.02 to 1.38)2.08 (1.96 to 2.20)
Number of cardiometabolic comorbidities (ref: 0)*
11.46 (1.39 to 1.54)1.11 (1.05 to 1.17)2.23 (1.86 to 2.67)1.44 (1.31 to 1.57)1.88 (1.48 to 2.39)1.04 (0.89 to 1.22)1.37 (1.21 to 1.54)1.19 (1.00 to 1.41)1.52 (1.42 to 1.62)
22.04 (1.93 to 2.15)1.22 (1.16 to 1.29)4.59 (3.85 to 5.46)1.74 (1.58 to 1.91)2.60 (2.05 to 3.30)1.40 (1.19 to 1.63)1.38 (1.21 to 1.58)1.17 (0.98 to 1.41)2.18 (2.04 to 2.33)
>23.10 (2.92 to 3.29)1.42 (1.34 to 1.51)8.01 (6.73 to 9.53)2.23 (2.02 to 2.47)4.24 (3.35 to 5.38)1.46 (1.23 to 1.73)2.03 (1.77 to 2.32)1.21 (0.99 to 1.48)3.41 (3.18 to 3.66)
  • *Separate models, adjusted for sex, age and ethnicity.